Clinical Reproduction and Fertility, 1(2), 131-135
A preliminary study of 'screened' women with two consecutive miscarriages revealed an incidence of abortion in 47.4% in a subsequent pregnancy whilst hCG therapy in a similar group of women where biochemical monitoring with plasma progesterone suggested a potentially jeopardized pregnancy resulted in a continuing pregnancy in 92.3% of treated women. An urgent need for a true randomized double-blind evaluation of this therapy has been established in order to re-examine the therapeutic nihilism which currently pervades the management of women with recurrent abortion.
Svigos, J. (1982). Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion. *Clinical reproduction and fertility*, *1*(2), 131-135.
Svigos J. Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion. Clin Reprod Fertil. 1982;1(2):131-135.
Svigos, John. "Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion." *Clinical reproduction and fertility*, vol. 1, no. 2, 1982, pp. 131-135.
Abortion, Habitual/prevention & Control, Chorionic Gonadotropin/therapeutic Use, Female, Humans, Pregnancy, Progesterone/blood, Chorionic Gonadotropin, Progesterone,